Oya M - Search Results

1

Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor.

Hara S, Oya M, Mizuno R, Horiguchi A, Marumo K, Murai M. Hara S, et al. Among authors: oya m. Ann Oncol. 2005 Jun;16(6):928-33. doi: 10.1093/annonc/mdi182. Epub 2005 Apr 25. Ann Oncol. 2005. PMID: 15851405 Free article.

2

Biochemical modulation of 5-fluorouracil with murine interferon-alpha/beta against murine renal cell carcinoma.

Marumo K, Oya M, Murai M. Marumo K, et al. Among authors: oya m. Int J Urol. 1997 Mar;4(2):163-8. doi: 10.1111/j.1442-2042.1997.tb00164.x. Int J Urol. 1997. PMID: 9179690 Free article.

3

The prediction of renal function 6 years after unilateral nephrectomy using preoperative risk factors.

Ito K, Nakashima J, Hanawa Y, Oya M, Ohigashi T, Marumo K, Murai M. Ito K, et al. Among authors: oya m. J Urol. 2004 Jan;171(1):120-5. doi: 10.1097/01.ju.0000100981.11470.2f. J Urol. 2004. PMID: 14665858

4

Pharmacokinetics and antitumor effects of an interleukin-2 immunocomplexing agent in murine renal cell carcinoma.

Oya M, Marumo K, Murai M, Tazaki H. Oya M, et al. Int J Urol. 1996 Mar;3(2):141-4. doi: 10.1111/j.1442-2042.1996.tb00499.x. Int J Urol. 1996. PMID: 8689509 Free article.

5

Application of the interferon minipellet to human renal cell carcinoma in nude mice.

Marumo K, Oya M, Murai M. Marumo K, et al. Among authors: oya m. Int J Urol. 1997 Jan;4(1):55-61. doi: 10.1111/j.1442-2042.1997.tb00141.x. Int J Urol. 1997. PMID: 9179668 Free article.

6

Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.

Oya M, Ohtsubo M, Takayanagi A, Tachibana M, Shimizu N, Murai M. Oya M, et al. Oncogene. 2001 Jun 28;20(29):3888-96. doi: 10.1038/sj.onc.1204525. Oncogene. 2001. PMID: 11439352

7

Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in mice.

Marumo K, Oya M, Murai M, Tazaki H. Marumo K, et al. Among authors: oya m. Int J Urol. 1996 Jan;3(1 Suppl):S24-7. doi: 10.1111/j.1442-2042.1996.tb00077.x. Int J Urol. 1996. PMID: 24304015 Free article.

8

Serum interleukin 6 as a prognostic factor in patients with prostate cancer.

Nakashima J, Tachibana M, Horiguchi Y, Oya M, Ohigashi T, Asakura H, Murai M. Nakashima J, et al. Among authors: oya m. Clin Cancer Res. 2000 Jul;6(7):2702-6. Clin Cancer Res. 2000. PMID: 10914713

9

Prognostic value of alkaline phosphatase flare in patients with metastatic prostate cancer treated with endocrine therapy.

Nakashima J, Ozu C, Nishiyama T, Oya M, Ohigashi T, Asakura H, Tachibana M, Murai M. Nakashima J, et al. Among authors: oya m. Urology. 2000 Nov 1;56(5):843-7. doi: 10.1016/s0090-4295(00)00755-x. Urology. 2000. PMID: 11068314

10

Application of conditionally replicating herpes vector for gene therapy treatment of urologic neoplasms.

Oyama M, Yazaki T, Ohigashi T, Hoshi M, Horiguchi Y, Oya M, Asakura H, Nakashima J, Tachibana M, Uyemura K, Murai M. Oyama M, et al. Among authors: oya m. Mol Urol. 2000 Summer;4(2):83-7. doi: 10.1089/10915360050138639. Mol Urol. 2000. PMID: 12006247 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,236 results

Search Page

Filters